Their validation of TXNDC11 revealed that the protein was highly expressed in MM cell lines; however, it showed primarily intracellular localization and was considered a false-positive of their scoring system (Ferguson et al. 2022). This evidence concerns the gene TXNDC11 and Miyoshi myopathy.